Need Regulatory Help? Try Our Platform
Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.
January 13, 2026
Approximately 5 minutes
Labelling and Instructions for Use Requirements for Medical Devices in New Zealand
Labelling and Instructions for Use Requirements for Medical Devices in New Zealand
1. Legal Basis
The labelling of medical devices in New Zealand is governed by Regulation 12(4) of the Medicines Regulations 1984, which requires that no person shall sell any medical device that does not bear the name of the manufacturer of the medical device or the name of the manufacturer's distributor in New Zealand. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp All medical devices must be clearly labelled with the name of the manufacturer or the manufacturer's distributor (sponsor) to comply. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp
There are no specific legislative or regulatory requirements for instructions for use (IFU) for medical devices under the Medicines Act 1981 or Medicines Regulations 1984. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp However, contraceptive products must include IFU as specified in the relevant approved Standard for that product type, and failure to do so would be a breach of the Contraception, Sterilisation and Abortion Act 1977. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp
2. Essential Principles
Medical devices are expected to be labelled in accordance with international best practice. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp Medsafe recommends that sponsors and manufacturers apply the guidance contained in the Global Harmonisation Task Force (GHTF) Study Group 1 final document, GHTF/SG1/N43:2005, for labelling and instructions for use. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp
For clinical trials, Medsafe recommends that any medical device supplied for the purpose of a clinical trial is clearly labelled as being for clinical trial use only and should also be labelled with the reference number of the clinical trial. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp
All medical devices are expected to be supplied with appropriate instructions for use (IFU), following international best practice. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp
3. Detailed Labelling Elements
Mandatory labelling includes the name of the manufacturer or the manufacturer's distributor (sponsor). https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp
4. IFU Specifics
IFU must be supplied appropriately with all medical devices. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp Medsafe recognises the trend towards electronic formats for IFU and permits their supply in New Zealand, including files supplied with the device on read-only media, files downloadable from the internet, and help files displayed by the device. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp However, the sponsor must be able to provide a hardcopy of the IFU upon request from a user. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp
For contraceptive products, IFU must comply with the relevant approved Standard. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp
5. Additional Notes
The GHTF guidance (GHTF/SG1/N43:2005) is recommended for both labelling and IFU development. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp
No specific requirements for different device classes (e.g., active, implantable, IVD, custom-made), exemptions, or language requirements are detailed in the content. https://www.medsafe.govt.nz/Devices/labelling-and-ifu.asp
Ask Anything
We'll follow up with you personally.
Related Articles
Approximately 5 minutes
In Vitro Diagnostic Devices Regulatory Framework in New Zealand
In vitro diagnostic (IVD) devices in New Zealand are regulated as medical devices under the Medicines Act 1981, classified into four risk-based classes (1 to 4), requiring conformity assessment, WAND notification, and compliance with essential principles, with specific rules for self-testing, near-patient testing, and high-risk IVDs such as those for blood screening or serious diseases.
Approximately 5 minutes
Advertising Requirements for Medical Devices in New Zealand
Medical devices in New Zealand are subject to advertising restrictions under the Medicines Act 1981, prohibiting therapeutic claims to the public unless the device is listed in the WAND database or meets specific exemptions, with strict controls on misleading representations, prohibited claims for serious conditions, and requirements for balanced information including risks and limitations.
Approximately 5 minutes
Conducting Clinical Trials with Medical Devices in New Zealand
Clinical trials involving medical devices in New Zealand do not require formal approval from Medsafe but must comply with ethical review by an accredited ethics committee, adhere to relevant standards such as ISO 14155, and follow good clinical practice principles, with sponsors responsible for safety monitoring, adverse event reporting, and trial conduct oversight.